This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Malta, Netherlands, Poland, Romania, South Africa, Spain, UK.
The drug DIPROSALIC contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
826Y60901U - BETAMETHASONE DIPROPIONATE
|
|
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
2
|
UNII
O414PZ4LPZ - SALICYLIC ACID
|
|
Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| DIPROSALIC Ointment | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D07XC01 | Betamethasone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XC Corticosteroids, potent, other combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 540917050029217, 540917050029317, 540917060031117 |
| CA | Health Products and Food Branch | 00578436 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 367310813 |
| EE | Ravimiamet | 1006041, 1006074, 1062403, 1062425, 1062436, 1734713, 1865123, 1880805, 1880816 |
| ES | Centro de información online de medicamentos de la AEMPS | 57463 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 082040, 418673 |
| FR | Base de données publique des médicaments | 64435022, 66707065 |
| GB | Medicines & Healthcare Products Regulatory Agency | 138669, 138671, 143208, 143211, 161591, 161697, 182527, 19266, 19990, 19992 |
| HK | Department of Health Drug Office | 23072 |
| IE | Health Products Regulatory Authority | 21474 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 1244, 1245 |
| MT | Medicines Authority | AA565/11102, AA565/11105 |
| NL | Z-Index G-Standaard | 12331600, 12360449 |
| NL | Z-Index G-Standaard, PRK | 16861 |
| PL | Rejestru Produktów Leczniczych | 100019516, 100019522, 100257612, 100258534, 100258729, 100265132, 100266077, 100269383, 100326141, 100326566, 100338859, 100345486, 100352760, 100359666, 100413532, 100422778, 100425765, 100440109, 100443770, 100468906 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W68209001, W68210001 |
| ZA | Health Products Regulatory Authority | H/13.4.1/32, L/13.4.1/66 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.